O-2 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: Final results from FIGHT-202

Peter Vogel, V. Sahai, Antoine Hollebecque, Gina M. Vaccaro, Davide Melisi, Raed Moh’d Taiseer Al-Rajabi, S. Paulson, M.J. Borad, David Gallinson, Adrian Murphy, Dong Yoon Oh, Efrat Dotan, Daniel V.T. Catenacci, E. Van Cutsem, Christine Lihou, Hui‐Ling Zhen, L. Veronese, Ghassan K. Abou‐Alfa